Efficacy of Upadacitinib in Treating Atopic Dermatitis in Sensitive Regions: Outcomes from a Multicenter Real-World Study on Hand, Head/Neck, and Genital Involvement - Scorecard - MDSpire

Efficacy of Upadacitinib in Treating Atopic Dermatitis in Sensitive Regions: Outcomes from a Multicenter Real-World Study on Hand, Head/Neck, and Genital Involvement

  • By

  • Francisco Javier Melgosa Ramos

  • Santiago Guillén-Climent

  • Raquel Cavestany Rodriguez

  • Javier Sabater-Abad

  • Antonio Martorell

  • Fátima Tous Romero

  • February 22, 2026

  • 0 min

Share

Clinical Scorecard: Efficacy of Upadacitinib in Treating Atopic Dermatitis in Sensitive Regions: Outcomes from a Multicenter Real-World Study on Hand, Head/Neck, and Genital Involvement

At a Glance

CategoryDetail
Condition
Key MechanismsBroad JAK1 inhibition targeting Th1, Th2, and Th17 pathways, emphasizing its role in sensitive areas.
Target Population
Care Setting

Key Highlights

  • Include specific data points or percentages to support claims.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • S
      • p
      • e
      • c
      • i
      • f
      • y
      • t
      • h
      • e
      • f
      • r
      • e
      • q
      • u
      • e
      • n
      • c
      • y
      • o
      • f
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • s
      • f
      • o
      • r
      • l
      • o
      • c
      • a
      • l
      • s
      • e
      • v
      • e
      • r
      • i
      • t
      • y
      • .

      Risks

        Patient & Prescribing Data

        Detail specific dosing regimens or adjustments based on patient characteristics.

        Clinical Best Practices

        • follow_up

        References

        Original Source(s)

        Efficacy of Upadacitinib in Treating Atopic Dermatitis in Sensitive Regions: Outcomes from a Multicenter Real-World Study on Hand, Head/Neck, and Genital Involvement

        • by Francisco Javier Melgosa Ramos, Santiago Guillén-Climent, Raquel Cavestany Rodriguez, Javier Sabater-Abad, Antonio Martorell, Fátima Tous Romero

        • February 22, 2026

        Related Content

        Overview of Findings: Real-World Outcomes of Systemic Therapies for Moderate-to-Severe Atopic Dermatitis in Children Aged 12 and Younger from the PEDISTAD Registry

        Global trends and academic landscapes of AI applications in basal cell carcinoma research: a bibliometric analysis

        Anti-PD-1 monoclonal antibody combined with chemotherapy for porocarcinoma: a case report and literature review